So that is No. 1. No. 2, there is no question that being independent in energy makes us a stronger country in terms of our national defense and our foreign policy; is that not correct?

Few issues in the public health today are as grave and urgent as combating the growing threat antibiotic resistance.

No. 3, we will have more jobs, more employment, less inflation, and a more vibrant economy if we were developing this petroleum; is that not correct?

Mr. Speaker, I rise in opposition to H.R. 4. The special interest bills that make up this package have all passed the House before and went nowhere in the Senate. This is not just a waste of time, it is a waste of taxpayer money. Americans…

if we go down the route of trying to beat up corporate America in this process, we are not going to be friends.

Mr. Speaker, the chairman of the Rules Committee has actually read the bills that are in this package and knows that they are much more than what my colleague and friend from Colorado just described. Because actually, the forestry…

The business model to whether it is going to be in diagnostics or testing is the same business decisions that we make in our home. It is simply about risk and reward.

I thank the chairman of the Natural Resources Committee who has been most helpful in our endeavors in the West on the issues of private property, water rights, improving the health of our forest, and diminishing wildfires through active…

Mr. Speaker, it is with a great sense of disappointment that I deliver my remarks today. For the past 21 months, this House has failed to take any meaningful action to reduce unemployment or boost job creation in America. We know what the…

Well, I would suggest that we may be better off putting much more money into biomedical research at NIH and throughout universities around the country because they don't have the profit motive and what they do helps the companies because…

if we do not confront the threat of antibiotic resistance, we could be "cast back into the dark ages of medicine where treatable infections and injuries will kill once again."

GAIN did not fully fix the problem, and much more is needed if we are to incentivize the type of drug development needed to combat this global threat.

Antimicrobial resistance (AMR) is an increasingly serious threat to global public health.

the GAIN Act was an important first step in the fight against antibiotic resistance and a great example of how bipartisan collaboration on this committee can save lives.

GAIN didn't fully fix the problem and much more is needed if we are to incentivize the type of drug development needed.

My legislation--the Preservation of Antibiotics for Medical Treatment Act -would save eight critical classes of antibiotics for human use while still allowing the treatment of sick animals.

Do you believe that we need to further incentivize new drug and diagnostic development if we are to appropriately address the issue of antibiotic resistance, and if so, what would you recommend?

We must preserve those antibiotics critical to human health for use in treating disease--not for growth promotion or disease prevention.